Cargando…

Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis

BACKGROUND: Postoperative docetaxel plus S-1 (DS) chemotherapy is expected to be the standard therapeutic strategy for pStage III gastric cancer based on the results of the JACCRO GC-07 study. Neoadjuvant chemotherapy (NAC) is thought to have several advantages over adjuvant settings. OBJECTIVE: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kano, Masayuki, Hayano, Koichi, Hayashi, Hideki, Hanari, Naoyuki, Gunji, Hisashi, Toyozumi, Takeshi, Murakami, Kentaro, Uesato, Masaya, Ota, Satoshi, Matsubara, Hisahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Gastrointestinal Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510880/ https://www.ncbi.nlm.nih.gov/pubmed/30977014 http://dx.doi.org/10.1245/s10434-019-07299-7

Ejemplares similares

Probable IgG4-related sclerosing disease presenting as a gastric submucosal tumor with an intense tracer uptake on PET/CT: a case report
por: Otsuka, Ryota, et al.
Publicado: (2016)

Laparoscopic double-tract reconstruction after total gastrectomy for postoperative duodenal surveillance: Case series
por: Otsuka, Ryota, et al.
Publicado: (2017)

Short‐term clinical outcomes of laparoscopic gastrectomy for remnant gastric cancer: A single‐institution experience and systematic review of the literature
por: Otsuka, Ryota, et al.
Publicado: (2018)

Magnetic compression anastomosis is effective in treating stenosis after esophageal cancer surgery: a case report
por: Isozaki, Tetsuro, et al.
Publicado: (2020)

A case report of duodenal arteriovenous malformation: usefulness of intraoperative indocyanine green angiography for precise identification of the lesion
por: Kurata, Yoshihiro, et al.
Publicado: (2022)

Why is endosonography insufficient for residual diagnosis after neoadjuvant therapy for esophageal cancer? Solutions using muscle layer evaluation
por: Yonemoto, Shohei, et al.
Publicado: (2022)

Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy
por: Hayano, Koichi, et al.
Publicado: (2020)

Caspase recruitment domain family member 9 expression is a promising biomarker in esophageal squamous cell carcinoma
por: Sekino, Nobufumi, et al.
Publicado: (2019)

Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma
por: Sekino, Nobufumi, et al.
Publicado: (2018)

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study
por: Burtness, Barbara, et al.
Publicado: (2016)

Preserving the Mucosa to the Maximum Possible Extent for Endoscopic Submucosal Dissection of Subcircumferential Superficial Esophageal Carcinoma
por: Uesato, Masaya, et al.
Publicado: (2018)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

Drill needle aspiration biopsy for submucosal tumors in an experimental study
por: Uesato, Masaya, et al.
Publicado: (2016)

Soluble PD‑L1 reflects cachexia status in patients with gastric cancer and is an independent prognostic marker for relapse‑free survival after radical surgery
por: Matsumoto, Yasunori, et al.
Publicado: (2023)

Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma
por: Matsumoto, Yasunori, et al.
Publicado: (2016)

Gastric endoscopic submucosal dissection via gastrostoma before the second operation for esophageal perforation: A case report
por: Sasaki, Takuma, et al.
Publicado: (2018)

Predictor of respiratory disturbances during gastric endoscopic submucosal dissection under deep sedation
por: Aikawa, Mizuho, et al.
Publicado: (2020)

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
por: Moore, Jonathan L., et al.
Publicado: (2023)

Addition of HER2 and CD44 to (18)F-FDG PET–based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer
por: Beukinga, Roelof J., et al.
Publicado: (2020)

Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS)
por: Toxopeus, Eelke, et al.
Publicado: (2018)

A case of small-cell esophageal cancer with chronic renal failure undergoing hemodialysis safely treated with cisplatin and etoposide
por: Murakami, Kentaro, et al.
Publicado: (2011)

Tumor‐derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines
por: Matsumoto, Yasunori, et al.
Publicado: (2020)

Foreign-body granulomas and abscesses caused by dropped gallstones after cholecystectomy: Four cases diagnosed with multimodality imaging
por: Sato, Shigetaka, et al.
Publicado: (2020)

Polysomnographic assessment of respiratory disturbance during deep propofol sedation for endoscopic submucosal dissection of gastric tumors
por: Urahama, Ryuma, et al.
Publicado: (2018)

Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi‐institutional propensity score‐matched study
por: Bracale, Umberto, et al.
Publicado: (2021)

Occurrence of Cortical Arousal at Recovery from Respiratory Disturbances during Deep Propofol Sedation
por: Urahama, Ryuma, et al.
Publicado: (2019)

Large bowel obstruction caused by urinary retention from benign prostate hyperplasia
por: Fujisaki, Tomohiro, et al.
Publicado: (2018)

Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels
por: Arasawa, Takahiro, et al.
Publicado: (2023)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603
por: Kawamoto, Yasuyuki, et al.
Publicado: (2022)

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer
por: de Heer, E. C., et al.
Publicado: (2017)

Prognostic Significance of Lymphatic, Venous and Perineural Invasion After Neoadjuvant Chemotherapy in Patients with Gastric Adenocarcinoma
por: Woodham, Benjamin L., et al.
Publicado: (2020)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma
por: Liu, Yong, et al.
Publicado: (2018)

Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer
por: Kobayashi, Satoshi, et al.
Publicado: (2022)

The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)
por: Bendell, Johanna C., et al.
Publicado: (2019)

Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer
por: Nederlof, Nina, et al.
Publicado: (2016)

Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study
por: Moriwaki, Toshikazu, et al.
Publicado: (2017)

Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

A case report of pulmonary tumor thrombotic microangiopathy (PTTM) caused by esophageal squamous cell carcinoma
por: Fujishiro, Takeshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3q79827hevrnmspc8eqhun3agl